Disclosure of Unlabeled Use and Investigational Product
Expiration Date: July 1, 2025
Experts will discuss the diagnosis and ongoing management of geographic atrophy. Discussion points will be directed by the KOLs but may cover topics such as what criteria are needed for diagnosing GA, how to adopt an interprofessional care approach, when to refer patients to a retina specialist, how to monitor patients at risk for GA and once they develop GA, when to initiate treatment for GA, strategies for selecting between treatments and for improving patient comfort during treatment, and how to proceed with care when a treatment does not work or stops working (eg, switch to the other complement inhibitor, enroll in a clinical trial).
This activity is designed for ophthalmologists, retina specialists, optometrists, and other healthcare professionals involved in the care of patients with GA.
Upon completion of the educational activity, participants should be able to:
To obtain a certificate of completion, a score of 70% or better on the post-test is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your certificate. You must participate in the entire activity to receive credit. There is no fee to participate in this activity. If you have questions about this activity, please contact AKH Inc. at
ketrea@akhcme.com
CE credit provided by AKH Inc., Advancing Knowledge in Healthcare
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and International Healthcare Media, LLC. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of .25
AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AKH Inc., Advancing Knowledge in Healthcare designates this asynchronous activity for a maximum of .25 COPE credit hours. Optometrists should claim only the credit commensurate with the extent of their participation in the activity.
This activity is supported by independent educational grants from Iveric Bio, an Astellas Company.
Name
Relationship
Commercial Interest
Ajay E. Kuriyan, MD (faculty)
Researcher
4DMT, Adverum, Annexon, Alcon Laboratories, Genentech/Roche
Speaker
Iveric Bio, an Astellas Company
Sumit Sharma, MD
Consultant
Alimera, Iveric Bio, an Astellas Company, Apellis, Bausch and Lomb, Genentech/Roche, Regeneron, Kodiak, Ripple, Priovant, Eyepoint
Researcher
Acelyrin, Genentech/Roche, IONIS
Dorothy Caputo, Ma, BSN, RN - VP, Healthcare Continuing Education and Operations
N/A
Nothing to disclose
Michele Bielarski, RN (planner/reviewer)
N/A
Nothing to disclose
AKH Inc Staff and Planners
N/A
Nothing to disclose
International Healthcare Media dba International Healthcare Education Staff and Planners
N/A
Nothing to disclose
Disclosures
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose. If you would like to opt out from future communications from AKH please send an email to optout@akhcme.com with your information with "Opt Out" in the subject line.
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content.